@tamsenfadal's HRT claims for menopause, fact-checked

What did @tamsenfadal actually say?

Fadal shared a personal hormone therapy routine: a twice-weekly estradiol patch changed on Monday and Thursday, plus nightly oral progesterone. She has been on this regimen for just over a year. Her words were measured: "I'm not a doctor, but I wanted to share my experience." She credited progesterone specifically for sleep improvement and described the overall protocol as making "a huge difference" with her menopause symptoms. She did not name doses, brands, or recommend anyone follow her exact routine.

This is worth noting because most hormone content on Instagram swings to extremes, either fearmongering or breathless promotion. Fadal's framing stayed personal and experience-based, which is the appropriate lane for a non-clinician.

Does the science back this up?

Yes, the core claims hold up well. The estradiol patch twice weekly and oral progesterone at night is a standard, evidence-supported menopausal hormone therapy (MHT) regimen, and the sleep benefit from progesterone specifically has research behind it.

On estradiol: transdermal delivery avoids first-pass liver metabolism, which matters for clotting risk. A 2019 analysis by Vinogradova et al. in the BMJ confirmed that transdermal estradiol carries a lower venous thromboembolism risk than oral estrogen. That is a clinically relevant distinction many creators skip entirely.

On progesterone and sleep: a 2008 randomized trial by Caufriez et al. in the journal Sleep showed that oral micronized progesterone increased slow-wave sleep and reduced awakenings in postmenopausal women. Fadal's description of sleep improvement maps directly onto that mechanism. Progesterone acts on GABA-A receptors through its metabolite allopregnanolone, producing sedative effects, which is why it is typically taken at night.

The broader symptom relief claim is also well supported. The 2022 NICE menopause guideline and multiple Cochrane reviews confirm MHT effectiveness for vasomotor symptoms, mood disruption, and sleep.

What did they get wrong (or right)?

Honestly, not much is wrong here. The bigger issue is what was left unsaid, and that is less Fadal's fault than a format constraint.

She does not mention that this regimen works for women with a uterus because progesterone protects the uterine lining from estrogen-driven proliferation. Women who have had a hysterectomy typically do not need progestogen. That distinction matters clinically but is not something a personal anecdote video is obligated to cover.

What she got plainly right: recommending people consult a healthcare provider, not overstating her credentials, and separating her personal experience from medical advice. These are things many wellness influencers fail at. Credit where it is due.

One minor concern: the video is tagged under TRT and testosterone replacement therapy categories on this platform. Her routine involves no testosterone. Estradiol and progesterone are not testosterone. That categorization mismatch could mislead viewers searching for testosterone-specific information, though that is a platform tagging issue, not a creator error.

What should you actually know?

If you are considering menopausal hormone therapy, here is what the current evidence actually supports.

• Transdermal estradiol (patches, gels) carries lower clotting risk than oral estrogen, per Vinogradova et al. (2019, BMJ). This matters if you have cardiovascular risk factors.
• Oral micronized progesterone (not synthetic progestins like medroxyprogesterone acetate) appears to have a more favorable side effect profile and the sleep benefit Fadal describes. These are not interchangeable, and the distinction matters when talking to your doctor.
• The old fear around hormone therapy largely stems from the 2002 Women's Health Initiative study, which used oral conjugated equine estrogen plus synthetic progestin, not transdermal estradiol plus micronized progesterone. The research landscape has shifted considerably since then, per Manson et al. (2013, JAMA Internal Medicine).
• MHT is not appropriate for everyone. A personal history of certain hormone-sensitive cancers, uncontrolled hypertension, or active liver disease are contraindications. A real clinical evaluation is not optional.
• Fadal says she "saw many doctors" before deciding. That is not inefficiency, that is due diligence, and it is a reasonable model for a decision with this much individual variability.

Bottom line

This video is one of the more responsible pieces of hormone content circulating on Instagram right now. Fadal stays in her lane, cites personal experience rather than clinical authority, and points viewers to healthcare providers. The regimen she describes is evidence-based and commonly prescribed. The sleep benefit from progesterone is not a placebo story. If there is a criticism, it is that 302,000 viewers deserve a little more context about who this regimen does and does not apply to, but that is a systemic gap in social media health content, not a unique failure here.